Skip to main content

Kineret (anakinra) is a medication used to treat certain inflammatory conditions such as rheumatoid arthritis (RA), Cryopyrin-Associated Periodic Syndromes (CAPS), and deficiency of interleukin-1 receptor antagonist (DIRA), an ultra-rare autoinflammatory disease. This therapeutic drug is supplied as a 100 mg/0.67 mL solution for subcutaneous (SC) injection. While Kineret 100 mg/0.67 mL injection can be effective in managing these conditions, it’s important to be aware of its safety considerations.

  • Infections: Kineret may increase the risk of serious infections, including bacterial, fungal, and viral infections. Patients should be monitored for signs of infection during treatment, and Kineret should be discontinued if a serious infection occurs.
  • Allergic Reactions: Some patients may experience allergic reactions to Kineret, which can manifest as rash, hives, swelling, or difficulty breathing. Patients should seek prompt medical help in case they experience any signs or symptoms of an allergic reaction.
  • Injection Site Reactions: Common side effects of Kineret include injection site reactions such as redness, swelling, or pain. Changing injection sites and using appropriate injection techniques can help reduce these reactions.
  • Blood Disorders: Kineret may cause changes in blood cell counts, including decreases in white blood cells, platelets, and hemoglobin levels. Regular blood tests may be necessary to monitor for these changes.
  • Hepatic and Renal Effects: Patients with pre-existing liver or kidney conditions should use Kineret with caution, as it may exacerbate these conditions. Liver function tests and renal function tests should be monitored regularly during treatment.
  • Pregnancy and Breastfeeding: The safety of Kineret during pregnancy and breastfeeding has not been established. Women who are pregnant or breastfeeding should consult with their healthcare provider before starting or continuing treatment with Kineret.
  • Malignancies: There have been reports of malignancies, including lymphoma, in patients treated with Kineret. Patients should be monitored for signs of malignancy during treatment.
  • Interactions: Kineret may interact with other medications, including immunosuppressive agents, leading to an increased risk of infection or other adverse effects. Patients should inform their healthcare provider of all medications they are taking before starting Kineret.

In Summary:
While Kineret injection can be an effective treatment for inflammatory conditions, it is important to be aware of its safety considerations. Patients should discuss any concerns or questions about Kineret with their healthcare provider before starting treatment. Close monitoring and regular follow-up appointments can help ensure the safe and effective use of this medicinal product in managing inflammatory conditions.


Nitin Goswami

Nitin Goswami joined us as an Editor in 2020. He covers all the updates in the field of Pharmaceutical, Business Healthcare, Health News, Medical News, and Pharma News.

Leave a Reply

Close Menu